198 related articles for article (PubMed ID: 32440483)
1. Hepatocyte TMEM16A Deletion Retards NAFLD Progression by Ameliorating Hepatic Glucose Metabolic Disorder.
Guo JW; Liu X; Zhang TT; Lin XC; Hong Y; Yu J; Wu QY; Zhang FR; Wu QQ; Shang JY; Lv XF; Ou JS; Zhou JG; Pang RP; Tang BD; Liang SJ
Adv Sci (Weinh); 2020 May; 7(10):1903657. PubMed ID: 32440483
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte-specific TMEM16A deficiency alleviates hepatic ischemia/reperfusion injury via suppressing GPX4-mediated ferroptosis.
Guo J; Song Z; Yu J; Li C; Jin C; Duan W; Liu X; Liu Y; Huang S; Tuo Y; Pei F; Jian Z; Zhou P; Zheng S; Zou Z; Zhang F; Gong Q; Liang S
Cell Death Dis; 2022 Dec; 13(12):1072. PubMed ID: 36572666
[TBL] [Abstract][Full Text] [Related]
3. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte Kctd17 Inhibition Ameliorates Glucose Intolerance and Hepatic Steatosis Caused by Obesity-induced Chrebp Stabilization.
Oh AR; Jeong Y; Yu J; Minh Tam DT; Kang JK; Jung YH; Im SS; Lee SB; Ryu D; Pajvani UB; Kim K
Gastroenterology; 2023 Mar; 164(3):439-453. PubMed ID: 36402191
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte NLRP3 interacts with PKCε to drive hepatic insulin resistance and steatosis.
Qin W; Weng J
Sci Bull (Beijing); 2023 Jul; 68(13):1413-1429. PubMed ID: 37336688
[TBL] [Abstract][Full Text] [Related]
8. Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway.
Chang TC; Chiou WC; Lai WH; Huang HC; Huang YL; Liu HK; Liang YC; Huang C
Pharmacol Res; 2021 Jan; 163():105298. PubMed ID: 33220422
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.
Long Z; Cao M; Su S; Wu G; Meng F; Wu H; Liu J; Yu W; Atabai K; Wang X
Free Radic Biol Med; 2017 Dec; 113():71-83. PubMed ID: 28942246
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity.
Chen Z; Canet MJ; Sheng L; Jiang L; Xiong Y; Yin L; Rui L
Mol Metab; 2015 Dec; 4(12):951-60. PubMed ID: 26909311
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of vesicle-associated membrane protein (VAMP) 3, but not VAMP2, protects glucose transporter (GLUT) 4 protein translocation in an in vitro model of cardiac insulin resistance.
Schwenk RW; Angin Y; Steinbusch LK; Dirkx E; Hoebers N; Coumans WA; Bonen A; Broers JL; van Eys GJ; Glatz JF; Luiken JJ
J Biol Chem; 2012 Oct; 287(44):37530-9. PubMed ID: 22936810
[TBL] [Abstract][Full Text] [Related]
12. The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance.
Zhang QY; Zhao LP; Tian XX; Yan CH; Li Y; Liu YX; Wang PX; Zhang XJ; Han YL
Hepatology; 2017 Sep; 66(3):834-854. PubMed ID: 28508477
[TBL] [Abstract][Full Text] [Related]
13. USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity.
An S; Zhao LP; Shen LJ; Wang S; Zhang K; Qi Y; Zheng J; Zhang XJ; Zhu XY; Bao R; Yang L; Lu YX; She ZG; Tang YD
Hepatology; 2017 Dec; 66(6):1866-1884. PubMed ID: 28718215
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.
Gao L; Wang PX; Zhang Y; Yu CJ; Ji Y; Wang X; Zhang P; Jiang X; Jin H; Huang Z; Zhang ZR; Li H
J Hepatol; 2016 Jul; 65(1):125-136. PubMed ID: 27032381
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte Adenosine Kinase Promotes Excessive Fat Deposition and Liver Inflammation.
Li H; Zheng J; Xu Q; Yang Y; Zhou J; Guo X; Cai Y; Cai JJ; Xie L; Awika J; Han X; Li Q; Kennedy L; Francis H; Glaser S; Huo Y; Alpini G; Wu C
Gastroenterology; 2023 Jan; 164(1):134-146. PubMed ID: 36181835
[TBL] [Abstract][Full Text] [Related]
16. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
17. Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway.
Lu Y; Jiang Z; Dai H; Miao R; Shu J; Gu H; Liu X; Huang Z; Yang G; Chen AF; Yuan H; Li Y; Cai J
Hepatology; 2018 Apr; 67(4):1303-1319. PubMed ID: 29091299
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
Yin X; Liu Z; Wang J
Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease.
Wang H; Zhao Y; Pan Y; Yang A; Li C; Wang S; Dong Z; Li M; Wang S; Zhang Z; Zhu Y; Zhang D; Sun G
JHEP Rep; 2023 Jun; 5(6):100726. PubMed ID: 37138676
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice.
Zhou ST; Cui W; Kong L; Yang X
Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
